FDA Drug Application (021044) for PALLADONE by PURDUE PHARMA LP

Back to FDA Applications sponsored by PURDUE PHARMA LP

Application Number021044
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage12MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePALLADONE
Active IngredientHYDROMORPHONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient HYDROMORPHONE HYDROCHLORIDE5


Back to FDA Applications sponsored by PURDUE PHARMA LP